Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer.

Kelly, RJ; Lee, J; Bang, YJ; Almhanna, K; Murphy, MAB; Catenacci, DVT; Chung, HC; Wainberg, ZA; Gibson, M; Lee, KW; Bendell, JC; Denlinger, CS; Brohawn, PZ; He, P; McDevitt, J; Englert, J; Ku, GY

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):